Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Myovant Sciences Ltd (MYOV)

21.1 0.37 (1.78%)

04-20 16:01

Open:

20.87

Pre. Close:

20.73

High:

21.29

Low:

20.59

Volume:

61,028

Market Cap:

1310M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

21.309 - 21.459

21.459 - 21.575

Low:

20.312 - 20.47

20.47 - 20.592

Close:

20.893 - 21.138

21.138 - 21.329

Technical analysis  (as of: 2018-04-20 4:32:01 PM)

Overall:

      

Stoxline posted a SELL today, upgraded from strong sell. But this stock still is very strong for short side. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 28.19     One year: 32.93

Support:

Support1: 20.35    Support2: 18.01

Resistance:

Resistance1: 24.14    Resistance2: 28.19

Pivot:

21.34

Moving Averages:

MA(5): 21.61     MA(20): 21.07

MA(100): 15.45     MA(250): 13.87

MACD:

MACD(12,26): 1.01     Signal(12,26,9): 1.22

%K %D:

%K(14,3): 54.20     %D(3): 59.02

RSI:

RSI(14): 56.30

52-Week:

High: 24.137  Low: 9.92  Change(%): 72.4

Average Vol(K):

3-Month: 9485  10-Days 19850

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
MYOV has closed above bottom band by 41.0%. Bollinger Bands are 7.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-20T08:00:00-04:00
Myovant Sciences and PERIOD. Inc. Launch Partnership Focused on Empowering Women to Elevate the Conversation Around Period Health

2018-04-09T03:46:20-04:00
BioSci Research On Myovant Sciences (Part I): Is This A Big Winner In The Making?

2018-04-06T12:33:34-04:00
BioSci Rounds Report: Intercept Is Making A Comeback While Improving FDA Policy Can Help Geron

2018-04-04T08:00:00-04:00
Your Daily Pharma Scoop: Geron Update, Rigel Setback, Bio-Path Results

2018-04-03T09:25:48-04:00
Myovant announces Private Placement and At-the-Market Offering Program

2018-03-27T12:59:05-04:00
Midday Gainers / Losers (03/27/2018)

2018-03-06T17:00:00-05:00
Myovant Sciences to Present at Upcoming Investor Conferences

2018-02-22T11:53:40-05:00
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2017 Update

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

62.10

Shares Float (M)

60.40

% Held by Insiders

2.80

% Held by Institutions

Shares Short (K)

447

Shares Short Prior Month (K)

406

Stock Financials

EPS

-0.540

EPS Est. Current Year

-1.440

EPS Est. Next Year

-1.200

EPS Est. Next Quarter

-0.430

Forward EPS

-2.600

Book Value (p.s.)

16.820

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-70.3

Return on Equity (ttm)

-87.0

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.500

Qtrly Earnings Growth

Operating Cash Flow (M)

-92.93

Levered Free Cash Flow (M)

atoplab.com

Valuation

P/E

-39.07

P/E Growth Ratio

0.02

P/BV

1.25

P/S

P/CF

-14.10

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.